Continuing Medical Education (CME)
Long-Term Risks and Benefits of Costimulation Blocker Therapy After Kidney Transplantation
Credit: .25 AMA PRA Category 1 Credit™
Matthew J. Ellis, MD
This 15-minute activity features a brief video introduction by faculty expert Matthew Ellis, MD, who discusses the rationale for using costimulation blocker therapy in patients following kidney transplantation. The activity then continues with a text-based review of the risks and benefits of using costimulation blockade for immunosuppression after kidney transplantation, including mechanism of action, efficacy, and safety.
In collaboration with